STOCK TITAN

[8-K] Bespoke Extracts, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Analyzing...
Positive
  • None.
Negative
  • None.
false 0001409197 0001409197 2025-10-08 2025-10-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 8, 2025

 

Bespoke Extracts, Inc.
(Exact name of registrant as specified in its charter)

 

Nevada   000-52759   20-4743354
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

12001 E.33rd Ave Unit O

Aurora, CO 80010

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code (720-949-1143)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On October 8, 2025, Bespoke Extracts, Inc. (the “Company”) entered into an Amendment to Senior Note (the “Amendment”) with Infinity Management, LLC (the “Holder”) to amend the Senior Note dated September 26, 2023, with a principal amount of $849,500.00 (the “Note”). The Amendment modifies the Maturity Date of the Note from June 30, 2025, to June 30, 2027, as mutually agreed by the parties. The Amendment also includes a recital noting that on November 11, 2024, the parties mutually agreed to extend the Maturity Date until June 30, 2025, prior to this further extension.The Amendment does not alter other material terms of the Note, including the principal amount, interest rate, or payment obligations, which remain in effect as originally stated. The full text of the Amendment is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits – The following exhibits are filed as part of this report:

 

Exhibit No.   Description of Exhibit
99.1   Note amendment
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Bespoke Extracts, Inc.  
     
Date: October 8, 2025 By: /s/ Michael Feinsod
    Michael Feinsod
Chief Executive Officer

 

 

2

 

Bespoke Extracts

OTC:BSPK

BSPK Rankings

BSPK Latest News

BSPK Stock Data

2.82M
8.85M
20.64%
9.1%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Aurora